Helicobacter pylori virulence functions – indirect modulation

Helicobacter pylori virulence functions – indirect modulation refers to a therapeutic strategy that targets the physiological environment and host-pathogen interactions necessary for bacterial survival and pathogenicity, rather than targeting a single bacterial protein directly (Kusters et al., 2006). Helicobacter pylori utilizes several key virulence factors, most notably urease, which hydrolyzes urea to ammonia to neutralize gastric acid, and the CagA oncoprotein, which is translocated into host cells via a Type IV secretion system to disrupt cellular signaling (Amieva & Peek, 2016). Indirect modulation typically involves the administration of Proton Pump Inhibitors (PPIs) or Potassium-competitive acid blockers (P-CABs) to elevate gastric pH, which effectively neutralizes the evolutionary advantage provided by bacterial urease and creates an environment less conducive to H. pylori colonization (Malfertheiner et al., 2017). This approach also encompasses the use of bismuth salts, which provide a protective mucosal coating and exert multi-targeted inhibitory effects on bacterial enzymes and adhesion (Wroblewski et al., 2010). By modulating these functional processes, treatment regimens aim to eradicate the infection and prevent the progression of chronic gastritis to peptic ulcers or gastric adenocarcinoma. This strategy is a cornerstone of modern triple and quadruple therapy regimens used globally in clinical gastroenterology to manage H. pylori-associated diseases.

Other names

H. pylori virulence modulationIndirect inhibition of H. pylori pathogenicityModulation of Helicobacter pylori virulence factors

Indirect inhibition of bacterial survival and virulence through gastric pH elevation, disruption of urease-dependent acid neutralization, and interference with bacterial adhesion and host-cell signaling.